Volume 34 Number 2 January 15-22, 2015
Cancer
Economic evaluation of genetic screening for Lynch syndrome in Germany![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Severin F, et al. Genet Med 2015 Jan
Severin F, et al. Genet Med 2015 Jan
Emerging biomarkers in head and neck cancer in the era of genomics.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Hyunseok Kang, et al. Nature Reviews Clinical Oncology; 2015; 12:11-26
Hyunseok Kang, et al. Nature Reviews Clinical Oncology; 2015; 12:11-26
Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Pashayan N, et al. Genet Med 2015 Jan
Pashayan N, et al. Genet Med 2015 Jan
Prostate cancer risk prediction based on complete prostate cancer family history.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Albright F et al., Prostate. 2014 Nov 18.
Albright F et al., Prostate. 2014 Nov 18.
Screening for Lynch syndrome: It is time to shift the focus![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Kidambi TD & Terdiman JP Dig Dis Sci 2015 Jan
Kidambi TD & Terdiman JP Dig Dis Sci 2015 Jan
Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. ![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Gould-Suarez M, et al. Dig Dis Sci 2014 Dec;59(12)2913-26.
Gould-Suarez M, et al. Dig Dis Sci 2014 Dec;59(12)2913-26.
Should KRAS mutation still be used as a routine predictor of response to EGFR-TKIs in advanced non-small-cell lung cancer? A revaluation based on meta-analysis![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Ying M, et al. J Cancer Res Clin Oncol 2015 Jan
Ying M, et al. J Cancer Res Clin Oncol 2015 Jan
Validation of family cancer history data in high-risk families: The influence of cancer site, ethnicity, kinship degree, and multiple family reporters.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sxXumhA0XhqAQe-hpLoK75Gyq9-v-u71VvR2bJtPKvm5vpwZxiV8uusAW0r1K_c9XSTb6xnvITXkH9t7QIGC8PmczeMr6n8f0sHMejQSA3xtjWv6z8XY8r=s0-d)
Tehranifar P, et al. Am J Epidemiol. 2015 Jan 7. pii: kwu258.
Tehranifar P, et al. Am J Epidemiol. 2015 Jan 7. pii: kwu258.
No hay comentarios:
Publicar un comentario